Talking about accessing external innovation at Roche

At Roche we were one of the first companies to recognise the importance of external innovation. Roche Partnering was created more than 10 years ago with the aim of becoming the partner of choice for biotechnology companies and research institutes worldwide. Since then, we have maintained a model that values external innovation as highly as our own internally derived discoveries and established collaborations as the cornerstone of our R&D strategy. Sophie Kornowski-Bonnet, Global Head of Roche Partnering, talks about accessing external innovation.

Tags: Access to healthcare, Science